chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Fatigue, Headache
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/31 MODERNA, dose # 104/28, MODERNA, dose #2 08/16 pt cc: fatigue, headache, loss of taste or smell, myalgias, rhinorrhea exposure: unknown 08/16 COVID swab, result: detected
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/31 MODERNA, dose # 104/28, MODERNA, dose #2 08/16 pt cc: fatigue, headache, loss of taste or smell, myalgias, rhinorrhea exposure: unknown 08/16 COVID swab, result: detected
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Fatigue, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/13, Moderna, dose #1 03/15, Moderna, dose#2 08/12 pt cc: chills fatigue, exposure: unknown 08/16 COVID swab, result: detected 08/16 SARS-COV-2 LINEAGE B.1.617.2 08/16 SARS-COV-2 CLADE 21A DELTA
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Blood bicarbonate increased, Blood fibrinogen increased, Blood gases, Blood lactic acid
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/7, Pfizer, dose #1 01/29, Pfizer, dose #2 07/26 pt admitted ED, admit to medicine cc: cough, shob, dx: Acute hypoxic respiratory failure and COPD exacerbation LOS: 2 days 09/01 pt admitted ED, admit medicine cc: dx: covid pneumonia LOS: 16 days 08/03 pt cc: dyspnea, cough, exposure: unknown 08/16 CXR impression: New focal airspace consolidation in the mid to basilar right lung, suggesting bronchopneumonia or aspiration. Recommend follow-up to resolution. Chronic perihilar and bibasilar streaky opacities, suggestive of chronic bronchitis. Background of chronic lung changes and upper lobe predominant emphysema. 08/16 COVID swab, result: detected 08/16 LACTIC ACID result: result 0.95 08/16 SARS-COV-2 LINEAGE B.1.617.2 08/16 SARS-COV-2 CLADE 21A DELTA 08/21 ESR result: 21 08/21 FIBRINOGEN result: 459 08/21 DDIMER result: 0.53 08/21 ABG i-pH 7.45, i-PCO2, i-PO2 54, i-HCO3 32.2 08/26 CXR impression: Slightly improved bilateral airspace opacities with more conspicuous focal opacity projecting over the right upper lung zone. 08/27 ESR result: 6 08/27 Fibrinogen result: 232 08/27 DDIMER result: 1.94 08/28 ESR result: 3 08/28 Fibrinogen result: 210 08/28 DDIMER result: 0.45 08/30 FIBRINOGEN result: 197 08/30 DDIMER result: 0.31 08/30 ESR result: <1
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pH normal, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Chronic obstructive pulmonary disease
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/7, Pfizer, dose #1 01/29, Pfizer, dose #2 07/26 pt admitted ED, admit to medicine cc: cough, shob, dx: Acute hypoxic respiratory failure and COPD exacerbation LOS: 2 days 09/01 pt admitted ED, admit medicine cc: dx: covid pneumonia LOS: 16 days 08/03 pt cc: dyspnea, cough, exposure: unknown 08/16 CXR impression: New focal airspace consolidation in the mid to basilar right lung, suggesting bronchopneumonia or aspiration. Recommend follow-up to resolution. Chronic perihilar and bibasilar streaky opacities, suggestive of chronic bronchitis. Background of chronic lung changes and upper lobe predominant emphysema. 08/16 COVID swab, result: detected 08/16 LACTIC ACID result: result 0.95 08/16 SARS-COV-2 LINEAGE B.1.617.2 08/16 SARS-COV-2 CLADE 21A DELTA 08/21 ESR result: 21 08/21 FIBRINOGEN result: 459 08/21 DDIMER result: 0.53 08/21 ABG i-pH 7.45, i-PCO2, i-PO2 54, i-HCO3 32.2 08/26 CXR impression: Slightly improved bilateral airspace opacities with more conspicuous focal opacity projecting over the right upper lung zone. 08/27 ESR result: 6 08/27 Fibrinogen result: 232 08/27 DDIMER result: 1.94 08/28 ESR result: 3 08/28 Fibrinogen result: 210 08/28 DDIMER result: 0.45 08/30 FIBRINOGEN result: 197 08/30 DDIMER result: 0.31 08/30 ESR result: <1
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Cough, Dyspnoea, Emphysema, Fibrin D dimer
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/7, Pfizer, dose #1 01/29, Pfizer, dose #2 07/26 pt admitted ED, admit to medicine cc: cough, shob, dx: Acute hypoxic respiratory failure and COPD exacerbation LOS: 2 days 09/01 pt admitted ED, admit medicine cc: dx: covid pneumonia LOS: 16 days 08/03 pt cc: dyspnea, cough, exposure: unknown 08/16 CXR impression: New focal airspace consolidation in the mid to basilar right lung, suggesting bronchopneumonia or aspiration. Recommend follow-up to resolution. Chronic perihilar and bibasilar streaky opacities, suggestive of chronic bronchitis. Background of chronic lung changes and upper lobe predominant emphysema. 08/16 COVID swab, result: detected 08/16 LACTIC ACID result: result 0.95 08/16 SARS-COV-2 LINEAGE B.1.617.2 08/16 SARS-COV-2 CLADE 21A DELTA 08/21 ESR result: 21 08/21 FIBRINOGEN result: 459 08/21 DDIMER result: 0.53 08/21 ABG i-pH 7.45, i-PCO2, i-PO2 54, i-HCO3 32.2 08/26 CXR impression: Slightly improved bilateral airspace opacities with more conspicuous focal opacity projecting over the right upper lung zone. 08/27 ESR result: 6 08/27 Fibrinogen result: 232 08/27 DDIMER result: 1.94 08/28 ESR result: 3 08/28 Fibrinogen result: 210 08/28 DDIMER result: 0.45 08/30 FIBRINOGEN result: 197 08/30 DDIMER result: 0.31 08/30 ESR result: <1
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Lung consolidation, Lung disorder, Lung opacity, PCO2, PO2 decreased
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/7, Pfizer, dose #1 01/29, Pfizer, dose #2 07/26 pt admitted ED, admit to medicine cc: cough, shob, dx: Acute hypoxic respiratory failure and COPD exacerbation LOS: 2 days 09/01 pt admitted ED, admit medicine cc: dx: covid pneumonia LOS: 16 days 08/03 pt cc: dyspnea, cough, exposure: unknown 08/16 CXR impression: New focal airspace consolidation in the mid to basilar right lung, suggesting bronchopneumonia or aspiration. Recommend follow-up to resolution. Chronic perihilar and bibasilar streaky opacities, suggestive of chronic bronchitis. Background of chronic lung changes and upper lobe predominant emphysema. 08/16 COVID swab, result: detected 08/16 LACTIC ACID result: result 0.95 08/16 SARS-COV-2 LINEAGE B.1.617.2 08/16 SARS-COV-2 CLADE 21A DELTA 08/21 ESR result: 21 08/21 FIBRINOGEN result: 459 08/21 DDIMER result: 0.53 08/21 ABG i-pH 7.45, i-PCO2, i-PO2 54, i-HCO3 32.2 08/26 CXR impression: Slightly improved bilateral airspace opacities with more conspicuous focal opacity projecting over the right upper lung zone. 08/27 ESR result: 6 08/27 Fibrinogen result: 232 08/27 DDIMER result: 1.94 08/28 ESR result: 3 08/28 Fibrinogen result: 210 08/28 DDIMER result: 0.45 08/30 FIBRINOGEN result: 197 08/30 DDIMER result: 0.31 08/30 ESR result: <1
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate increased, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 01/7, Pfizer, dose #1 01/29, Pfizer, dose #2 07/26 pt admitted ED, admit to medicine cc: cough, shob, dx: Acute hypoxic respiratory failure and COPD exacerbation LOS: 2 days 09/01 pt admitted ED, admit medicine cc: dx: covid pneumonia LOS: 16 days 08/03 pt cc: dyspnea, cough, exposure: unknown 08/16 CXR impression: New focal airspace consolidation in the mid to basilar right lung, suggesting bronchopneumonia or aspiration. Recommend follow-up to resolution. Chronic perihilar and bibasilar streaky opacities, suggestive of chronic bronchitis. Background of chronic lung changes and upper lobe predominant emphysema. 08/16 COVID swab, result: detected 08/16 LACTIC ACID result: result 0.95 08/16 SARS-COV-2 LINEAGE B.1.617.2 08/16 SARS-COV-2 CLADE 21A DELTA 08/21 ESR result: 21 08/21 FIBRINOGEN result: 459 08/21 DDIMER result: 0.53 08/21 ABG i-pH 7.45, i-PCO2, i-PO2 54, i-HCO3 32.2 08/26 CXR impression: Slightly improved bilateral airspace opacities with more conspicuous focal opacity projecting over the right upper lung zone. 08/27 ESR result: 6 08/27 Fibrinogen result: 232 08/27 DDIMER result: 1.94 08/28 ESR result: 3 08/28 Fibrinogen result: 210 08/28 DDIMER result: 0.45 08/30 FIBRINOGEN result: 197 08/30 DDIMER result: 0.31 08/30 ESR result: <1
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Exposure to SARS-CoV-2, Fatigue, Headache
Clinical narrative: Narrative: COVID infection following COVID vaccine series 05/03 COVID-19 SCR NOT DETECTED 07/23, Pfizer, dose #1 08/13, Pfizer, dose #2 08/13 COVID swab, result: detected 08/14 pt cc: cough, fatigue, headache, myalgias, nausea exposure: daughter
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Nausea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 05/03 COVID-19 SCR NOT DETECTED 07/23, Pfizer, dose #1 08/13, Pfizer, dose #2 08/13 COVID swab, result: detected 08/14 pt cc: cough, fatigue, headache, myalgias, nausea exposure: daughter
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Chemotherapy, Immunodeficiency, Neoplasm malignant
Clinical narrative: Narrative:  Patient was given Moderna COVID vaccine dose #1 on 3/4. He was given Moderna COVID vaccine dose #2 on 4/1. He is considered immunocompromised due to active cancer and on chemotherapy. He was contacted by the facility on 8/24 to schedule a 3rd dose and came into get a 3rd dose on 8/26 at which time he was vaccinated with Pfizer covid vaccine. The patient has not had any adverse effects from any doses of the vaccine. An incident report was entered at the facility level.
Age: 28.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Cardio-respiratory arrest, Cataplexy, Chills, Facial paralysis, Full blood count normal
Clinical narrative: Narrative:  Pt at vaccine clinic, received her COVID-19 vaccine (Moderna) and flu shot. While on observation, 15 minutes post vaccine administration, she became limp and minimally responsive. Pt brought to Urgent Care, noted with left sided facial droop. Pt report has numbness/left sided weakness. Pt state she gets (L)side hemiparesis (Todd's paralysis) when she gets migraines. Vital Signs * Temperature Pulse 81, Respirations 16, Blood Pressure 142/63, Pain scale recorded: 99, Pulse Oximetry 99 Room Air. Code blue called. Responded to Code Blue, pt noted with lips shivering, Code blue called. Responded to Code Blue, pt noted with lips shivering, responding minimally and slowly, but appropriate. Pt brought to room 2, Placed on cardiac and pulse ox monitor. FS 74, #20g IV access placed to (L) AC and secured. MD at bedside evaluating pt. Pt to be sent to non agency Hospital. 911 called and booked. MR arrived for transport. Outcome unknown. No further documentation in patients chart to date regarding this issue. Patient did return to facility on 9/30/21 for a physical therapy appt unrelated to this issue. There was no documentation or reference in the physical therapy note on 9/30/21 regarding the adverse event that occurred on 9/20/21.
Age: 28.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Glycosylated haemoglobin normal, Hemiparesis, Hypoaesthesia, Hyporesponsive to stimuli, Laboratory test normal
Clinical narrative: Narrative:  Pt at vaccine clinic, received her COVID-19 vaccine (Moderna) and flu shot. While on observation, 15 minutes post vaccine administration, she became limp and minimally responsive. Pt brought to Urgent Care, noted with left sided facial droop. Pt report has numbness/left sided weakness. Pt state she gets (L)side hemiparesis (Todd's paralysis) when she gets migraines. Vital Signs * Temperature Pulse 81, Respirations 16, Blood Pressure 142/63, Pain scale recorded: 99, Pulse Oximetry 99 Room Air. Code blue called. Responded to Code Blue, pt noted with lips shivering, Code blue called. Responded to Code Blue, pt noted with lips shivering, responding minimally and slowly, but appropriate. Pt brought to room 2, Placed on cardiac and pulse ox monitor. FS 74, #20g IV access placed to (L) AC and secured. MD at bedside evaluating pt. Pt to be sent to non agency Hospital. 911 called and booked. MR arrived for transport. Outcome unknown. No further documentation in patients chart to date regarding this issue. Patient did return to facility on 9/30/21 for a physical therapy appt unrelated to this issue. There was no documentation or reference in the physical therapy note on 9/30/21 regarding the adverse event that occurred on 9/20/21.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Intermenstrual bleeding, Menstruation irregular
Clinical narrative: Narrative: Patient reports that she started her period the day she got the J&J Vaccine (9/10) and this was 2 weeks early for her. Also has an IUD and often doesn't even get periods. She had been bleeding through 9/22/21 which is when she notified the primary care clinic of the reaction. By then she called it " spotting. Blood was dark brown.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Abscess drainage, Computerised tomogram abdomen abnormal, Death, Drain placement, Dysphagia
Clinical narrative: Narrative:  Patient is an 82 yo male with PMHx COPD, HLD, HTN, GERD with hx of esophageal stricture s/p dilation 2009), anemia, chronic venous htn, and RA who presented to MC ED 9/7/21 c/o difficulty swallowing food, nausea, and general malaise x several months, steadily worsening. SIRS 2/4, WBC 24.4 and HR 114 OA. CT a/p concerning for psoas abscess; surgery consulted and recommended IR. UA with infectious signs, air in the nephric space concerning for complicated UTI vs translocative infection in the setting of psoas abscess, started on vanc/cefepime. Patient was admitted for further work up and treatment. IR performed CT guided abscess drainage yesterday 9/9/2021 with successful placement of drain into left lower quadrant to drain the lateral inferior abscess, and successful placement of drain through the left flank to drain the perinephric abscess. GI performed EGD yesterday 9/9/21 and found intrinsic 8 mm stricture that was 5 cm long and appeared at 35 cm; dilated to 10mm. Additional findings suggestive of candidal esophagitis. Hospice and palliative medicine consulted for Goals of care. Patient is known to palliative medicine service from prior admission May 2021. Patient was transitioned to comfort care in inpatient hospice unit 9/15/21. Pt then died on 9/17/2021 at hospital during inpatient hospice admission. Per MD death note, "Death was caused by: Severe Protein-Calorie Malnutrition" Pt had received one covid vaccine on 4/9/2021. Death is not related to covid vaccine.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Infection, Malaise, Malnutrition, Nausea, Oesophageal candidiasis
Clinical narrative: Narrative:  Patient is an 82 yo male with PMHx COPD, HLD, HTN, GERD with hx of esophageal stricture s/p dilation 2009), anemia, chronic venous htn, and RA who presented to MC ED 9/7/21 c/o difficulty swallowing food, nausea, and general malaise x several months, steadily worsening. SIRS 2/4, WBC 24.4 and HR 114 OA. CT a/p concerning for psoas abscess; surgery consulted and recommended IR. UA with infectious signs, air in the nephric space concerning for complicated UTI vs translocative infection in the setting of psoas abscess, started on vanc/cefepime. Patient was admitted for further work up and treatment. IR performed CT guided abscess drainage yesterday 9/9/2021 with successful placement of drain into left lower quadrant to drain the lateral inferior abscess, and successful placement of drain through the left flank to drain the perinephric abscess. GI performed EGD yesterday 9/9/21 and found intrinsic 8 mm stricture that was 5 cm long and appeared at 35 cm; dilated to 10mm. Additional findings suggestive of candidal esophagitis. Hospice and palliative medicine consulted for Goals of care. Patient is known to palliative medicine service from prior admission May 2021. Patient was transitioned to comfort care in inpatient hospice unit 9/15/21. Pt then died on 9/17/2021 at hospital during inpatient hospice admission. Per MD death note, "Death was caused by: Severe Protein-Calorie Malnutrition" Pt had received one covid vaccine on 4/9/2021. Death is not related to covid vaccine.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Oesophageal stenosis, Oesophagogastroduodenoscopy abnormal, Perinephric abscess, Psoas abscess, Systemic inflammatory response syndrome
Clinical narrative: Narrative:  Patient is an 82 yo male with PMHx COPD, HLD, HTN, GERD with hx of esophageal stricture s/p dilation 2009), anemia, chronic venous htn, and RA who presented to MC ED 9/7/21 c/o difficulty swallowing food, nausea, and general malaise x several months, steadily worsening. SIRS 2/4, WBC 24.4 and HR 114 OA. CT a/p concerning for psoas abscess; surgery consulted and recommended IR. UA with infectious signs, air in the nephric space concerning for complicated UTI vs translocative infection in the setting of psoas abscess, started on vanc/cefepime. Patient was admitted for further work up and treatment. IR performed CT guided abscess drainage yesterday 9/9/2021 with successful placement of drain into left lower quadrant to drain the lateral inferior abscess, and successful placement of drain through the left flank to drain the perinephric abscess. GI performed EGD yesterday 9/9/21 and found intrinsic 8 mm stricture that was 5 cm long and appeared at 35 cm; dilated to 10mm. Additional findings suggestive of candidal esophagitis. Hospice and palliative medicine consulted for Goals of care. Patient is known to palliative medicine service from prior admission May 2021. Patient was transitioned to comfort care in inpatient hospice unit 9/15/21. Pt then died on 9/17/2021 at hospital during inpatient hospice admission. Per MD death note, "Death was caused by: Severe Protein-Calorie Malnutrition" Pt had received one covid vaccine on 4/9/2021. Death is not related to covid vaccine.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Urinary tract infection, Urine analysis abnormal, White blood cell count increased
Clinical narrative: Narrative:  Patient is an 82 yo male with PMHx COPD, HLD, HTN, GERD with hx of esophageal stricture s/p dilation 2009), anemia, chronic venous htn, and RA who presented to MC ED 9/7/21 c/o difficulty swallowing food, nausea, and general malaise x several months, steadily worsening. SIRS 2/4, WBC 24.4 and HR 114 OA. CT a/p concerning for psoas abscess; surgery consulted and recommended IR. UA with infectious signs, air in the nephric space concerning for complicated UTI vs translocative infection in the setting of psoas abscess, started on vanc/cefepime. Patient was admitted for further work up and treatment. IR performed CT guided abscess drainage yesterday 9/9/2021 with successful placement of drain into left lower quadrant to drain the lateral inferior abscess, and successful placement of drain through the left flank to drain the perinephric abscess. GI performed EGD yesterday 9/9/21 and found intrinsic 8 mm stricture that was 5 cm long and appeared at 35 cm; dilated to 10mm. Additional findings suggestive of candidal esophagitis. Hospice and palliative medicine consulted for Goals of care. Patient is known to palliative medicine service from prior admission May 2021. Patient was transitioned to comfort care in inpatient hospice unit 9/15/21. Pt then died on 9/17/2021 at hospital during inpatient hospice admission. Per MD death note, "Death was caused by: Severe Protein-Calorie Malnutrition" Pt had received one covid vaccine on 4/9/2021. Death is not related to covid vaccine.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Guillain-Barre syndrome, Immunoglobulin therapy, Magnetic resonance imaging head normal, Magnetic resonance imaging spinal normal, Muscular weakness
Clinical narrative: Narrative:  Patient received J&J vaccine on 5/28/2021. He reported hand tingling ~2 weeks after receiving vaccination. Tingling progressed to bilateral upper extremity weakness. On 9/22, patient presented to the ED at MC and reported leg weakness. NIF was -40. Patient denied difficulty breathing. MRI head and c-spine were negative for acute pathology. Neurological work up was negative for acute pathology. GBS suspected. Patient was given IVIG 0.5g/kg x 4 days.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Neurological examination normal, Paraesthesia
Clinical narrative: Narrative:  Patient received J&J vaccine on 5/28/2021. He reported hand tingling ~2 weeks after receiving vaccination. Tingling progressed to bilateral upper extremity weakness. On 9/22, patient presented to the ED at MC and reported leg weakness. NIF was -40. Patient denied difficulty breathing. MRI head and c-spine were negative for acute pathology. Neurological work up was negative for acute pathology. GBS suspected. Patient was given IVIG 0.5g/kg x 4 days.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Exposure to SARS-CoV-2, Pyrexia, Rhinorrhoea
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/02, Moderna, dose #1 03/30, Moderna, dose #2 08/14 SARS-COV-2 LINEAGAE result: AY.4 08/14 SARS-COV-2 CLADE result: 21A 08/14 COVID swab, result: detected 08/15 pt cc: fever, cough, rhinorrhea, exposure; boyfriend 08/14 COVID swab, result: d15etected
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/02, Moderna, dose #1 03/30, Moderna, dose #2 08/14 SARS-COV-2 LINEAGAE result: AY.4 08/14 SARS-COV-2 CLADE result: 21A 08/14 COVID swab, result: detected 08/15 pt cc: fever, cough, rhinorrhea, exposure; boyfriend 08/14 COVID swab, result: d15etected
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/03, Pfizer, dose #1 03/24, Pfizer, dose #2 08/14 pt cc: exposure: unknown 08/14 COVID swab, result: detected
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: Narrative: 09/17/2020 COVID swab, result: not detected COVID infection following COVID vaccine series 01/13, Pfizer, dose #1 02/04, Pfizer, dose #2 08/03 pt cc: cough, chills, rhinorrhea. sore throat exposure: unknown 08/14 COVID swab, result: detected 08/14 SARS-COV-2 LINEAGE result: AY.4 08/14 SARS-COV-2 CLADE result: 21A
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: 09/17/2020 COVID swab, result: not detected COVID infection following COVID vaccine series 01/13, Pfizer, dose #1 02/04, Pfizer, dose #2 08/03 pt cc: cough, chills, rhinorrhea. sore throat exposure: unknown 08/14 COVID swab, result: detected 08/14 SARS-COV-2 LINEAGE result: AY.4 08/14 SARS-COV-2 CLADE result: 21A
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/21 Moderna ,dose #1 03/24, Moderna , dose #2 08/14 COVID swab, result: detected 08/15 pt cc: exposure; unknown
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Dyspnoea, Fatigue, Headache
Clinical narrative: Headache, Myalgia, Fever, CoughWheeze, chills, fatigue, SHOB Narrative:
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia, Wheezing
Clinical narrative: Headache, Myalgia, Fever, CoughWheeze, chills, fatigue, SHOB Narrative:
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Fatigue, Headache, Myalgia
Clinical narrative: Headache, Myalgia, Fever, CoughWheeze, fatigue, chills Narrative:
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Wheezing
Clinical narrative: Headache, Myalgia, Fever, CoughWheeze, fatigue, chills Narrative:
Age: 0.58
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Injection site discomfort
Clinical narrative: Headache, Myalgia, Arthralgia, Fever, Injection site discomfort, fatigue, chills Narrative:
Age: 0.58
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Headache, Myalgia, Arthralgia, Fever, Injection site discomfort, fatigue, chills Narrative:
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache
Clinical narrative: Headache fatigue, chills Narrative:
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Injection site pain
Clinical narrative: Headache, Myalgia, Arthralgia, Fever, fatigue, chills, injection site pain Narrative:
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Headache, Myalgia, Arthralgia, Fever, fatigue, chills, injection site pain Narrative:
Age: 2.75
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Injection site pain
Clinical narrative: Headache, Myalgia, Arthralgia Fever, chills fatigue, injection site pain Narrative:
Age: 2.75
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Headache, Myalgia, Arthralgia Fever, chills fatigue, injection site pain Narrative:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Injection site pain, Myalgia
Clinical narrative: Myalgia, Arthralgia, Fever, chills fatigue, injection site pain Narrative:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Myalgia, Arthralgia, Fever, chills fatigue, injection site pain Narrative:
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Injection site pain
Clinical narrative: Headache, Myalgia, Arthralgia, fatigue, chills, injection site pain Narrative:
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Headache, Myalgia, Arthralgia, fatigue, chills, injection site pain Narrative:
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Injection site pain, Myalgia
Clinical narrative: Headache, Myalgia, Arthralgia, fatigue, injection site pain Narrative:
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Rash, Rash erythematous, Urticaria
Clinical narrative: Rash & UrticariaPruritus Narrative: Employee stopped by health to report/discuss onset of the above s/s about 4 hours after shot. Perioral and periorbital itchiness, ~ 2x3 inch red, flat rash over R cheekbone. new reaction, did not occur with first two shots.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Injection site erythema, Injection site pain
Clinical narrative: Headache chills, soreness/redness at injection site Narrative:
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Headache, Myalgia, Arthralgia, Fever, fatigue Narrative:
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: fatigue and body aches Narrative:
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: Fever chills Narrative:
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Angina pectoris, Balance disorder, Chills, Diplopia, Dizziness
Clinical narrative: Dizziness, Headache, Myalgia, Fever, NauseaVomiting, Angina, chills, shaking, sweating, vertigo, tinnitus, double vision, difficulty walking, , swelling in hands and feet, fatigue Narrative: Still feeling dizzy, with headache and mild nausea and taking Tylenol and Zofran. The vertigo has persisted despite meclizine treatment. Loss of balance head is moved quickly. Does not drive to vertigo. Still feels ill. Tinnitus, headache and utter exhaustion every day.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Gait disturbance, Headache, Hyperhidrosis, Impaired driving ability
Clinical narrative: Dizziness, Headache, Myalgia, Fever, NauseaVomiting, Angina, chills, shaking, sweating, vertigo, tinnitus, double vision, difficulty walking, , swelling in hands and feet, fatigue Narrative: Still feeling dizzy, with headache and mild nausea and taking Tylenol and Zofran. The vertigo has persisted despite meclizine treatment. Loss of balance head is moved quickly. Does not drive to vertigo. Still feels ill. Tinnitus, headache and utter exhaustion every day.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Nausea, Peripheral swelling, Pyrexia
Clinical narrative: Dizziness, Headache, Myalgia, Fever, NauseaVomiting, Angina, chills, shaking, sweating, vertigo, tinnitus, double vision, difficulty walking, , swelling in hands and feet, fatigue Narrative: Still feeling dizzy, with headache and mild nausea and taking Tylenol and Zofran. The vertigo has persisted despite meclizine treatment. Loss of balance head is moved quickly. Does not drive to vertigo. Still feels ill. Tinnitus, headache and utter exhaustion every day.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus, Tremor, Vertigo, Vomiting
Clinical narrative: Dizziness, Headache, Myalgia, Fever, NauseaVomiting, Angina, chills, shaking, sweating, vertigo, tinnitus, double vision, difficulty walking, , swelling in hands and feet, fatigue Narrative: Still feeling dizzy, with headache and mild nausea and taking Tylenol and Zofran. The vertigo has persisted despite meclizine treatment. Loss of balance head is moved quickly. Does not drive to vertigo. Still feels ill. Tinnitus, headache and utter exhaustion every day.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Myalgia
Clinical narrative: Headache, Myalgia, Arthralgia,  chills Narrative:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Headache, Hyperhidrosis
Clinical narrative: Headache, Myalgia, Arthralgia, chills, sweats, fatigue Narrative:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Headache, Myalgia, Arthralgia, chills, sweats, fatigue Narrative:
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Musculoskeletal stiffness, Myalgia
Clinical narrative: Headache. Myalgia, Arthralgia, fatigue, stiff neck Narrative:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Myalgia
Clinical narrative: Headache, Myalgia, Arthralgia, chills Narrative:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Lacrimation increased, Myalgia
Clinical narrative: Headache, Myalgia, Arthralgia, sneezing, chills, stuffy nose, eyes watering Narrative:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Nasal congestion, Sneezing
Clinical narrative: Headache, Myalgia, Arthralgia, sneezing, chills, stuffy nose, eyes watering Narrative:
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Fatigue, Headache
Clinical narrative: Fever, Diarrhea, NauseaVomiting, Local Reaction: Pain-discomfort , General symptoms: chills, fever, headaches, joint pains, muscle pains, fatigue, nausea, diarrhea.  Narrative:
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Local reaction, Myalgia, Nausea, Pain, Pyrexia
Clinical narrative: Fever, Diarrhea, NauseaVomiting, Local Reaction: Pain-discomfort , General symptoms: chills, fever, headaches, joint pains, muscle pains, fatigue, nausea, diarrhea.  Narrative:
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Fever, Diarrhea, NauseaVomiting, Local Reaction: Pain-discomfort , General symptoms: chills, fever, headaches, joint pains, muscle pains, fatigue, nausea, diarrhea.  Narrative:
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Dyspnoea, Fatigue
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/13, Pfizer, dose #1 02/03, Pfizer, dose #2 08/05 pt cc: chills, cough, fatigue, fever, rhinorrhea, dyspnea exposure; unknown 08/06 - 08/18 symptoms continue 08/16 COVID swab, result: detected 08/16 SARS-COV-2 LINEAGE AY.4 08/16 SARS-COV-2 CLADE 21A DELTA
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 01/13, Pfizer, dose #1 02/03, Pfizer, dose #2 08/05 pt cc: chills, cough, fatigue, fever, rhinorrhea, dyspnea exposure; unknown 08/06 - 08/18 symptoms continue 08/16 COVID swab, result: detected 08/16 SARS-COV-2 LINEAGE AY.4 08/16 SARS-COV-2 CLADE 21A DELTA
Age: 66.0
Sex: M
Vaccine: VARZOS
Symptoms: Gout, Peripheral swelling
Clinical narrative: Narrative:  Patient received a zoster vaccine on 8/20/21 and 7 days later he reported right upper extremity swelling. He was later diagnosed with gout in the right hand which was believed to have caused his right hand swelling. He received 1.2 mg colcichine and 5 days of indomethacin 50 mg.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Rash
Clinical narrative: Rash, Diarrhea, fatigue Narrative:
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Palpitations
Clinical narrative: Palpitations Palpitations on/off since the; headaches, chills and  muscle ache Narrative:
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Injection site pain, Myalgia
Clinical narrative: Myalgia, Arthralgia, pain injection site Narrative:
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash Narrative:
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site erythema, Injection site swelling, Injection site warmth, Myalgia
Clinical narrative: Myalgia SWOLLEN REGION AT INJECTION SITE RED AND WARM TO TOUGH, FATIGUE, MUSCLE AHCES Narrative:
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Injection site pain, Myalgia
Clinical narrative: Myalgia, Arthralgia, fatigue, injection site pain Narrative:
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Headache, Pyrexia
Clinical narrative: Headache, Fever, Diarrhea, chills Narrative:
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Feeling abnormal, Headache, Lymphadenopathy
Clinical narrative: Headache, Myalgia, Diarrhea,  fatigue, brain fog, swollen lymph node in left armpit Narrative:
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Headache, Myalgia, Diarrhea,  fatigue, brain fog, swollen lymph node in left armpit Narrative:
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia
Clinical narrative: Myalgia MUSCLE ACHES AND INCREASED FATIGUE Narrative:
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Fatigue, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: SWELLING, TENDERNESS, WARMTH AT INJECTION SITE, LOW GRADE TEMP, PAIN TO LEFT AXILLA AREA, FATIGUE Narrative:
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: SWELLING, TENDERNESS, WARMTH AT INJECTION SITE, LOW GRADE TEMP, PAIN TO LEFT AXILLA AREA, FATIGUE Narrative:
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Injection site discomfort, Myalgia, Pyrexia
Clinical narrative: Myalgia, Fever chills, fatigue, injection site discomfort Narrative:
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pain, Fatigue, Headache, Lymph node pain
Clinical narrative: Headache lymph nodes sores, eyes hurt, tired Narrative:
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Vomiting
Clinical narrative: Headache & NauseaVomiting Narrative:
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Fatigue, Pain, Pyrexia
Clinical narrative: Local Symptoms: Pain-discomfort, General discomfort: Fever, fatigue, other symptoms.  Narrative:
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pain, Pain in extremity
Clinical narrative: achy, headache, fatigue, sore right arm, Narrative:
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Nausea, Vomiting
Clinical narrative: Headache, Myalgia, NauseaVomiting, fatigue Narrative:
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Myalgia & Fever Narrative:
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pain, Headache, Nausea, Vomiting
Clinical narrative: Headache, NauseaVomiting, eyes hurting Narrative:
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Ear discomfort, Headache, Oropharyngeal pain, Respiratory tract congestion
Clinical narrative: congested, sore throat, headache, ears plugged Narrative:
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Hypoaesthesia, Myalgia, Neck pain, Nerve conduction studies
Clinical narrative: Left arm pain , with radiating pain into left arm, lt shoulder pain, left side lower neck pain, I have not mentioned too much to my provider as I thought it was just temporary muscular pain. I did see an orthopedic provider because I had some lt writs pain and numbness in my 4th and 5th finer w/trigger finger in my left thumb. I had a steroid injection in lt wrist which helped a couple of weeks or so and had a nerve conduction test still have trigger finer of lt. Thumb; biggest issue is pain in lt upper arm, lt. shoulder pain. I take Extra Strength Tylenol Arthritis, OTC Voltaren topical gel and use heating pad frequently. Pain keeps me up at night.
Age: 64.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Pain in extremity, Trigger finger, X-ray
Clinical narrative: Left arm pain , with radiating pain into left arm, lt shoulder pain, left side lower neck pain, I have not mentioned too much to my provider as I thought it was just temporary muscular pain. I did see an orthopedic provider because I had some lt writs pain and numbness in my 4th and 5th finer w/trigger finger in my left thumb. I had a steroid injection in lt wrist which helped a couple of weeks or so and had a nerve conduction test still have trigger finer of lt. Thumb; biggest issue is pain in lt upper arm, lt. shoulder pain. I take Extra Strength Tylenol Arthritis, OTC Voltaren topical gel and use heating pad frequently. Pain keeps me up at night.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Immediate post-injection reaction, Injection site swelling, Lymphadenopathy, Mammogram, Pain in extremity
Clinical narrative: Pain in right arm immediate after vaccine. Lymph nodes swelled under arm along with swelling in upper arm. ob/gyn ordered a mamogram and ultrasound of right breast. Swelling went away
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound Doppler, Ultrasound breast
Clinical narrative: Pain in right arm immediate after vaccine. Lymph nodes swelled under arm along with swelling in upper arm. ob/gyn ordered a mamogram and ultrasound of right breast. Swelling went away
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Bell's palsy, Facial paralysis
Clinical narrative: Yesterday I tested positive for a breakthrough case; Yesterday I tested positive for a breakthrough case; This is a spontaneous report from a contactable consumer (patient).  A 38-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 intramuscular, administered in Arm Right on 24Mar2021 13:00 (Lot Number: EL3248) and dose 1 intramuscular, administered in Arm Right on 04Mar2021 11:00 (Lot Number: EL3248); both as single doses (at the age of 38-years-old) for COVID-19 immunization. There was no medical history. No known allergies. No COVID prior vaccination. Concomitant medication included indapamide. No other vaccine in four weeks. The patient stated, "Yesterday I tested positive for a breakthrough case. I am not sure this is a reportable event. However, I want to make sure I am compliant with all my reporting requirements. I was vaccinated in Mar. Yesterday I tested positive for a breakthrough case" on 22Oct2021 13:00. The patient underwent lab tests and procedures which included SARS-CoV-2 test: positive on 22Oct2021 (Nasal Swab). Therapeutic measures were taken as a result of the events (series of medications prescribed by physician). The outcome of the events was recovering. The reporter assessed the events as non-serious.   Follow-up attempts are completed. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Bell's palsy, Fatigue, Joint stiffness, Pain, Pyrexia
Clinical narrative: Yesterday I tested positive for a breakthrough case; Yesterday I tested positive for a breakthrough case; This is a spontaneous report from a contactable consumer (patient).  A 38-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 intramuscular, administered in Arm Right on 24Mar2021 13:00 (Lot Number: EL3248) and dose 1 intramuscular, administered in Arm Right on 04Mar2021 11:00 (Lot Number: EL3248); both as single doses (at the age of 38-years-old) for COVID-19 immunization. There was no medical history. No known allergies. No COVID prior vaccination. Concomitant medication included indapamide. No other vaccine in four weeks. The patient stated, "Yesterday I tested positive for a breakthrough case. I am not sure this is a reportable event. However, I want to make sure I am compliant with all my reporting requirements. I was vaccinated in Mar. Yesterday I tested positive for a breakthrough case" on 22Oct2021 13:00. The patient underwent lab tests and procedures which included SARS-CoV-2 test: positive on 22Oct2021 (Nasal Swab). Therapeutic measures were taken as a result of the events (series of medications prescribed by physician). The outcome of the events was recovering. The reporter assessed the events as non-serious.   Follow-up attempts are completed. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Visual impairment
Clinical narrative: Yesterday I tested positive for a breakthrough case; Yesterday I tested positive for a breakthrough case; This is a spontaneous report from a contactable consumer (patient).  A 38-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 intramuscular, administered in Arm Right on 24Mar2021 13:00 (Lot Number: EL3248) and dose 1 intramuscular, administered in Arm Right on 04Mar2021 11:00 (Lot Number: EL3248); both as single doses (at the age of 38-years-old) for COVID-19 immunization. There was no medical history. No known allergies. No COVID prior vaccination. Concomitant medication included indapamide. No other vaccine in four weeks. The patient stated, "Yesterday I tested positive for a breakthrough case. I am not sure this is a reportable event. However, I want to make sure I am compliant with all my reporting requirements. I was vaccinated in Mar. Yesterday I tested positive for a breakthrough case" on 22Oct2021 13:00. The patient underwent lab tests and procedures which included SARS-CoV-2 test: positive on 22Oct2021 (Nasal Swab). Therapeutic measures were taken as a result of the events (series of medications prescribed by physician). The outcome of the events was recovering. The reporter assessed the events as non-serious.   Follow-up attempts are completed. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test, Vaccination failure
Clinical narrative: Yesterday I tested positive for a breakthrough case; Yesterday I tested positive for a breakthrough case; This is a spontaneous report from a contactable consumer (patient).  A 38-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 intramuscular, administered in Arm Right on 24Mar2021 13:00 (Lot Number: EL3248) and dose 1 intramuscular, administered in Arm Right on 04Mar2021 11:00 (Lot Number: EL3248); both as single doses (at the age of 38-years-old) for COVID-19 immunization. There was no medical history. No known allergies. No COVID prior vaccination. Concomitant medication included indapamide. No other vaccine in four weeks. The patient stated, "Yesterday I tested positive for a breakthrough case. I am not sure this is a reportable event. However, I want to make sure I am compliant with all my reporting requirements. I was vaccinated in Mar. Yesterday I tested positive for a breakthrough case" on 22Oct2021 13:00. The patient underwent lab tests and procedures which included SARS-CoV-2 test: positive on 22Oct2021 (Nasal Swab). Therapeutic measures were taken as a result of the events (series of medications prescribed by physician). The outcome of the events was recovering. The reporter assessed the events as non-serious.   Follow-up attempts are completed. No further information is expected.
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Dyspnoea, Electrocardiogram ST segment elevation, Pleuritic pain, Troponin I increased
Clinical narrative: Patient was awakened from sleep with crushing chest pain, jaw pain and sweating. I (his mother) took him immediately to the emergency department where he was found to have an abnormal EKG and cardiac troponin level over 6000. He was given  ketorolac IV, which gave him some relief. Then he was transferred to Hospital, where he was treated with steroids, IV IG, ketorolac and remained inpatient for 7 days.
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ultrasound scan normal
Clinical narrative: Patient was awakened from sleep with crushing chest pain, jaw pain and sweating. I (his mother) took him immediately to the emergency department where he was found to have an abnormal EKG and cardiac troponin level over 6000. He was given  ketorolac IV, which gave him some relief. Then he was transferred to Hospital, where he was treated with steroids, IV IG, ketorolac and remained inpatient for 7 days.
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cardiac imaging procedure abnormal, Chest pain, Electrocardiogram abnormal, Hyperhidrosis, Myocarditis
Clinical narrative: Patient was awakened from sleep with crushing chest pain, jaw pain and sweating. I (his mother) took him immediately to the emergency department where he was found to have an abnormal EKG and cardiac troponin level over 6000. He was given  ketorolac IV, which gave him some relief. Then he was transferred to Hospital, where he was treated with steroids, IV IG, ketorolac and remained inpatient for 7 days.
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain in jaw, Sleep disorder, Troponin increased
Clinical narrative: Patient was awakened from sleep with crushing chest pain, jaw pain and sweating. I (his mother) took him immediately to the emergency department where he was found to have an abnormal EKG and cardiac troponin level over 6000. He was given  ketorolac IV, which gave him some relief. Then he was transferred to Hospital, where he was treated with steroids, IV IG, ketorolac and remained inpatient for 7 days.
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Aspiration, Asthenia, Electromyogram, Endotracheal intubation, Guillain-Barre syndrome
Clinical narrative: Diagnosed with Guillan Barre Syndrome - Severe case - 7/1/21
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Immunoglobulin therapy, Lumbar puncture, Magnetic resonance imaging, Paraesthesia, Polyneuropathy
Clinical narrative: Diagnosed with Guillan Barre Syndrome - Severe case - 7/1/21
Age: 29.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Guillain-Barre syndrome, Laboratory test
Clinical narrative: Diagnosed with Guillan Barre Syndrome - Severe case - 7/1/21
Sex: F
Vaccine: PPV, FLUX, PPV
Symptoms: Muscular weakness, Neck pain, Pain
Clinical narrative: pain in the right arm that extends up into the neck; pain in the right arm that extends up into the neck; muscle weakness in the right arm; not being able to grab onto anything with the right arm; This spontaneous report was received from a patient care technician (PTC) concerning a 66-year-old female patient. The patient's medical history included lumpectomy in the right breast. The patient's concurrent conditions included allergy to amoxicillin and nylon.  On 07-OCT-2021 the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23), 0.5 milliliter (lot # and expiry date were unknown), intramuscular for prevention of pneumococcal disease.  On the same day, she was also vaccinated with unspecified influenza vaccine. Concomitant therapies included atorvastatin, metformin, alprazolam, ofloxacin, and prednisolone acetate.  On 08-OCT-2021, the patient presented to the office with complaints of "massive" pain in the right arm that extended up into the neck, not being able to grab onto anything with the right arm, and muscle weakness in the right arm that started in the morning (reported as "this am"). No treatment was given for the events.  At the time of reporting, the patient had not recovered from the events.  The causality assessment between the events and the vaccination with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) or unspecified influenza vaccine was not provided.